Clinical Trial

Urinary NGAL and KIM-1 After ESWL

Completed
View on ClinicalTrials.gov →
Summary
The goal of this prospective observational study is to evaluate the effect of different time intervals between extracorporeal shock wave lithotripsy (ESWL) sessions on renal injury using urinary biomarkers in patients with urinary system stone disease. The main questions it aims to answer are: Does the interval between consecutive ESWL sessions affect the degree of renal injury? Are urinary NGAL and KIM-1 levels reliable biomarkers for detecting ESWL-related renal damage? What is the optimal time interval between ESWL sessions to minimize renal injury? If there is a comparison group, researchers will compare patients undergoing ESWL with different inter-session time intervals to determine whether shorter or longer intervals are associated with higher levels of renal injury biomarkers. Participants will: Undergo ESWL treatment for urinary system stones Be assigned to one of two groups based on the time interval between ESWL sessions Provide urine samples before ESWL and after three ESWL sessions Have urinary NGAL and KIM-1 levels measured to assess renal injury
Trial Details
NCT Number NCT07341269
Lead Sponsor Marmara University
Conditions Urinary Stone, Renal Injury
Enrollment 50 participants
Start Date 2025-06-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2025-12-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-14